Rationale for combination chemotherapy

on 29.8.08 with 0 comments




  • maximize anti-tumor activity by using agents with different mechanisms of action

  • minimize toxicity by combining compounds with different toxicities

  • lots of drug, short duration of time


development of combination chemotherapy for testicular cancer

  • vinblastine: 20% partial remission (PR), 10% complete remission (CR)

  • vinblastine and bleomycin: 30% PR, 30% CR

  • vinblastine, bleomycine, and cisplatin: 35% PR, 65% CR

Category: Pharmacology Notes

POST COMMENT

0 comments:

Post a Comment